Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model
- PMID: 17405160
- DOI: 10.1002/jor.20382
Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model
Abstract
Mesenchymal stem cells (MSCs) provide an important source of pluripotent cells for musculoskeletal tissue repair. This study examined the impact of MSC implantation on cartilage healing characteristics in a large animal model. Twelve full-thickness 15-mm cartilage lesions in the femoropatellar articulations of six young mature horses were repaired by injection of a self-polymerizing autogenous fibrin vehicle containing mesenchymal stem cells, or autogenous fibrin alone in control joints. Arthroscopic second look and defect biopsy was obtained at 30 days, and all animals were euthanized 8 months after repair. Cartilage repair tissue and surrounding cartilage were assessed by histology, histochemistry, collagen type I and type II immunohistochemistry, collagen type II in situ hybridization, and matrix biochemical assays. Arthroscopic scores for MSC-implanted defects were significantly improved at the 30-day arthroscopic assessment. Biopsy showed MSC-implanted defects contained increased fibrous tissue with several defects containing predominantly type II collagen. Long-term assessment revealed repair tissue filled grafted and control lesions at 8 months, with no significant difference between stem cell-treated and control defects. Collagen type II and proteoglycan content in MSC-implanted and control defects were similar. Mesenchymal stem cell grafts improved the early healing response, but did not significantly enhance the long-term histologic appearance or biochemical composition of full-thickness cartilage lesions.
Copyright (c) 2007 Orthopaedic Research Society.
Similar articles
-
Enhanced repair of extensive articular defects by insulin-like growth factor-I-laden fibrin composites.J Orthop Res. 1999 Jul;17(4):475-87. doi: 10.1002/jor.1100170404. J Orthop Res. 1999. PMID: 10459752
-
Autologous chondrocyte implantation drives early chondrogenesis and organized repair in extensive full- and partial-thickness cartilage defects in an equine model.J Orthop Res. 2011 Jul;29(7):1121-30. doi: 10.1002/jor.21366. Epub 2011 Feb 11. J Orthop Res. 2011. PMID: 21319216
-
Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model.J Bone Joint Surg Br. 2007 May;89(5):672-85. doi: 10.1302/0301-620X.89B5.18343. J Bone Joint Surg Br. 2007. PMID: 17540757
-
Insulin-like growth factor-I enhances cell-based repair of articular cartilage.J Bone Joint Surg Br. 2002 Mar;84(2):276-88. doi: 10.1302/0301-620x.84b2.11167. J Bone Joint Surg Br. 2002. PMID: 11922373
-
Mesenchymal stem cells in the treatment of traumatic articular cartilage defects: a comprehensive review.Arthritis Res Ther. 2014;16(5):432. doi: 10.1186/s13075-014-0432-1. Arthritis Res Ther. 2014. PMID: 25606595 Free PMC article. Review.
Cited by
-
Atelocollagen Scaffold Enhances Cartilage Regeneration in Osteochondral Defects: A Study in Rabbits.Tissue Eng Regen Med. 2024 Feb;21(2):329-339. doi: 10.1007/s13770-023-00589-y. Epub 2023 Oct 18. Tissue Eng Regen Med. 2024. PMID: 37853285
-
Mesenchymal Stem Cells Isolated from Equine Hair Follicles Using a Method of Air-Liquid Interface.Stem Cell Rev Rep. 2023 Nov;19(8):2943-2956. doi: 10.1007/s12015-023-10619-w. Epub 2023 Sep 21. Stem Cell Rev Rep. 2023. PMID: 37733199 Free PMC article.
-
Gene therapy approaches for equine osteoarthritis.Front Vet Sci. 2022 Sep 28;9:962898. doi: 10.3389/fvets.2022.962898. eCollection 2022. Front Vet Sci. 2022. PMID: 36246316 Free PMC article. Review.
-
Long-term repair of porcine articular cartilage using cryopreservable, clinically compatible human embryonic stem cell-derived chondrocytes.NPJ Regen Med. 2021 Nov 23;6(1):77. doi: 10.1038/s41536-021-00187-3. NPJ Regen Med. 2021. PMID: 34815400 Free PMC article.
-
Recent Insight on the Non-coding RNAs in Mesenchymal Stem Cell-Derived Exosomes: Regulatory and Therapeutic Role in Regenerative Medicine and Tissue Engineering.Front Cardiovasc Med. 2021 Oct 1;8:737512. doi: 10.3389/fcvm.2021.737512. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34660740 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
